A carregar...
Enrollment and stopping rules for managing toxicity requiring long follow-up in Phase II oncology trials
Monitoring of toxicity is often conducted in Phase II trials in oncology to avoid an excessive number of toxicities if the wrong dose is chosen for Phase II. Existing stopping rules for toxicity use information from patients who have already completed follow-up. We describe a stopping rule that uses...
Na minha lista:
| Publicado no: | J Biopharm Stat |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4689581/ https://ncbi.nlm.nih.gov/pubmed/26383917 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10543406.2015.1086779 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|